Time dependent changes in high density lipoprotein cholesterol and cardiovascular risk

International Journal of Cardiology

Volumn 173, Issue 2, 2014, Pages 295-299

  Milwidsky, Assi ^a,b   Kivity, Shaye ^a,c   Kopel, Eran ^a   Klempfner, Robert ^a,c   Berkovitch, Anat ^a   Segev, Shlomo ^a   Sidi, Yechezkel ^a,c   Goldenberg, Ilan ^a,c   Maor, Elad ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cardiovascular risk; HDL cholesterol; Time dependent changes

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MALE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SMOKING; BLOOD; CARDIOVASCULAR DISEASES; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; INCIDENCE; KAPLAN MEIER METHOD; MIDDLE AGED; MOTOR ACTIVITY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; TIME;

ADULT; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOTOR ACTIVITY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SMOKING; TIME FACTORS;

EID: 84898655675     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.03.022     Document Type: Article

References (28)

1. W.P. Castelli, R.J. Garrison, P.W. Wilson, R.D. Abbott, S. Kalousdian, and W.B. Kannel Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study JAMA 256 20 1986 2835 2838
2. M.H. Frick, O. Elo, and K. Haapa et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease N Engl J Med 317 20 1987 1237 1245
3. U. Goldbourt, S. Yaari, and J.H. Medalie Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men Arterioscler Thromb Vasc Biol 17 1 1997 107 113
4. D.J. Gordon, and B.M. Rifkind High-density lipoprotein - the clinical implications of recent studies N Engl J Med 321 19 1989 1311 1316
5. A. Menotti, M. Lanti, and A. Zanchetti et al. The role of HDL cholesterol in metabolic syndrome predicting cardiovascular events. The Gubbio population study Nutr Metab Cardiovasc Dis 21 5 2011 315 322
6. J. Pekkanen, S. Linn, and G. Heiss et al. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease N Engl J Med 322 24 1990 1700 1707
7. H.B. Rubins, S.J. Robins, and D. Collins et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group N Engl J Med 341 6 1999 410 418
8. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 25 2002 3143 3421
9. E. Kopel, S. Kivity, N. Morag-Koren, S. Segev, and Y. Sidi Relation of serum lactate dehydrogenase to coronary artery disease Am J Cardiol 110 12 2012 1717 1722
10. E. Maor, S. Kivity, and E. Kopel et al. Differences in heart rate profile during exercise among subjects with subclinical thyroid disease Thyroid 23 10 2013 1226 1232
11. K. Shaye, T. Amir, S. Shlomo, and S. Yechezkel Fasting glucose levels within the high normal range predict cardiovascular outcome Am Heart J 164 1 2012 111 116
12. T.R. Dawber, G.F. Meadors, and F.E. Moore Jr. Epidemiological approaches to heart disease: the Framingham Study Am J Public Health Nations Health 41 3 1951 279 281
13. U. Goldbourt, and J.H. Medalie High density lipoprotein cholesterol and incidence of coronary heart disease - the Israeli Ischemic Heart Disease Study Am J Epidemiol 109 3 1979 296 308
14. T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T.R. Dawber High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study Am J Med 62 5 1977 707 714
15. D.J. Gordon, J.L. Probstfield, and R.J. Garrison et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies Circulation 79 1 1989 8 15
16. A.R. Sharrett, C.M. Ballantyne, and S.A. Coady et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study Circulation 104 10 2001 1108 1113
17. N.E. Miller, D.S. Thelle, O.H. Forde, and O.D. Mjos The Tromso heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study Lancet 1 8019 1977 965 968
18. H.B. Hubert, E.D. Eaker, R.J. Garrison, and W.P. Castelli Life-style correlates of risk factor change in young adults: an eight-year study of coronary heart disease risk factors in the Framingham offspring Am J Epidemiol 125 5 1987 812 831
19. M.L. Dansinger, J.A. Gleason, J.L. Griffith, H.P. Selker, and E.J. Schaefer Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial JAMA 293 1 2005 43 53
20. T.T. Sovik, E.T. Aasheim, and O. Taha et al. Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial Ann Intern Med 6 155 5 2011 281 291
21. S.L. Hardoon, P.H. Whincup, L.T. Lennon, S.G. Wannamethee, S. Capewell, and R.W. Morris How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study Circulation 117 5 2008 598 604
22. J.W. Hay, and K.L. Sterling Cost effectiveness of treating low HDL-cholesterol in the primary prevention of coronary heart disease Pharmacoeconomics 23 2 2005 133 141
23. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering JAMA 251 3 1984 365 374
24. W.E. Boden High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High Density Lipoprotein Intervention Trial Am J Cardiol 86 12A 2000 19L 22L
25. Y. Cui, D.J. Watson, and C.J. Girman et al. Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study) Am J Cardiol 104 6 2009 829 834
26. L. Tenkanen, M. Manttari, and V. Manninen Some coronary risk factors related to the insulin resistance syndrome and treatment with gemfibrozil. Experience from the Helsinki Heart Study Circulation 92 7 1995 1779 1785
27. I. Goldenberg, V. Boyko, A. Tennenbaum, D. Tanne, S. Behar, and V. Guetta Long-term benefit of high-density lipoprotein cholesterol-raising therapy with bezafibrate: 16-year mortality follow-up of the bezafibrate infarction prevention trial Arch Intern Med 169 5 2009 508 514
28. W.E. Boden, J.L. Probstfield, and T. Anderson et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy N Engl J Med 365 24 2011 2255 2267